Company Search:
Advanced Search
Sponsored Links
Infant Bacterial Therapeutics AB Company Snapshot
Infant Bacterial Therapeutics AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Infant Bacterial Therapeutics AB with three other pharmaceutical manufacturers in Europe: Nicox SA of France (2016 sales of 16,000.00 Euro [US$19,656.00 ] ), Index Pharmaceuticals Holding Ab (176,000.00 Swedish Kronor [US$20,838.40 ] ), and Irlab Therapeutics Ab (144,000.00 Swedish Kronor [US$17,049.60 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Infant Bacterial Therapeutics AB
  Stock Performance Chart for Infant Bacterial Therapeutics AB
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 159.50
(Figures in Swedish Kronor)
1 Week -1.5%   13 Weeks 39.3%  
4 Weeks 48.4%   52 Weeks 182.9%  
Infant Bacterial Therapeutics AB Key Data:
  Ticker: IBT B Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 162,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 980,772,099
  Fiscal Yr Ends: December Shares Outstanding: 6,149,041
  Share Type: Aktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.